TY - JOUR
T1 - Evaluating external contamination of polybrominated diphenyl ethers in human hair
T2 - Clinical and research implications
AU - Poon, Shirley
AU - Aleksa, Katarina
AU - Carnevale, Amanda
AU - Kapur, Bhushan
AU - Goodyer, Cindy
AU - Koren, Gideon
N1 - Publisher Copyright:
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2015/4/25
Y1 - 2015/4/25
N2 - Background: Human hair is a well-validated matrix for detecting a variety of xenobiotics, including drugs of abuse (cocaine, tetrahydrocannabinol, and morphine) and fatty acid ethyl ethers. Recent studies have shown that hair can also be useful in determining an individual's exposure to polybrominated diphenyl ethers (PBDEs), flame retardants that contaminate the dust in our daily environment. Hair processing before assay varies with each analyte; in particular, the wash protocol must be optimized to remove external contaminants while not affecting levels of the chemical of interest. The aim of this study was to determine whether hair needs to be washed before analysis for PBDEs, and if so, which protocol is most effective to ensure that the level of PBDEs is neither overestimated nor underestimated. Method: Individual hair samples from 10 adults (5 men and 5 women) were subjected to 4 different wash protocols: (1) no wash, (2) water, (3) 10% sodium dodecyl sulfate (SDS), and (4) hexane. Both the washes and hair were analyzed for 8 PBDEs by gas chromatography/mass spectrometry. Results: The sum of PBDEs (ΣPBDEs) in the washes was (1) no wash: 0 pg/mg, (2) water: 0.39 ± 0.19 (mean ± SEM), (3) 10% SDS: 1.34 ± 0.68, and (4) hexane: 1.92 ± 0.87. The ΣPBDEs in the hair were: (1) no wash: 20.32 ± 3.05, (2) water: 20.30 ± 2.41, (3) 10% SDS: 19.27 ± 1.87, and (4) hexane: 16.91 ± 2.89. Washing with water, 10% SDS, and hexane decreased the PBDE levels by 1.9%, 7%, and 11.4%, respectively (P < 0.05). Conclusions: Thus, of the washes evaluated, water is the wash that had the least effect on total PBDE concentrations, providing the best evaluation of an individual's exposure to PBDEs.
AB - Background: Human hair is a well-validated matrix for detecting a variety of xenobiotics, including drugs of abuse (cocaine, tetrahydrocannabinol, and morphine) and fatty acid ethyl ethers. Recent studies have shown that hair can also be useful in determining an individual's exposure to polybrominated diphenyl ethers (PBDEs), flame retardants that contaminate the dust in our daily environment. Hair processing before assay varies with each analyte; in particular, the wash protocol must be optimized to remove external contaminants while not affecting levels of the chemical of interest. The aim of this study was to determine whether hair needs to be washed before analysis for PBDEs, and if so, which protocol is most effective to ensure that the level of PBDEs is neither overestimated nor underestimated. Method: Individual hair samples from 10 adults (5 men and 5 women) were subjected to 4 different wash protocols: (1) no wash, (2) water, (3) 10% sodium dodecyl sulfate (SDS), and (4) hexane. Both the washes and hair were analyzed for 8 PBDEs by gas chromatography/mass spectrometry. Results: The sum of PBDEs (ΣPBDEs) in the washes was (1) no wash: 0 pg/mg, (2) water: 0.39 ± 0.19 (mean ± SEM), (3) 10% SDS: 1.34 ± 0.68, and (4) hexane: 1.92 ± 0.87. The ΣPBDEs in the hair were: (1) no wash: 20.32 ± 3.05, (2) water: 20.30 ± 2.41, (3) 10% SDS: 19.27 ± 1.87, and (4) hexane: 16.91 ± 2.89. Washing with water, 10% SDS, and hexane decreased the PBDE levels by 1.9%, 7%, and 11.4%, respectively (P < 0.05). Conclusions: Thus, of the washes evaluated, water is the wash that had the least effect on total PBDE concentrations, providing the best evaluation of an individual's exposure to PBDEs.
KW - PBDEs
KW - biomarker
KW - hair
KW - hair wash
KW - methods
UR - http://www.scopus.com/inward/record.url?scp=84925859071&partnerID=8YFLogxK
U2 - 10.1097/FTD.0000000000000137
DO - 10.1097/FTD.0000000000000137
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 25768972
AN - SCOPUS:84925859071
SN - 0163-4356
VL - 37
SP - 270
EP - 274
JO - Therapeutic Drug Monitoring
JF - Therapeutic Drug Monitoring
IS - 2
ER -